{"id":"corifollitropin-alfa","rwe":[{"pmid":"41637911","year":"2026","title":"Risk of progesterone elevation in patients with low ovarian reserve using long-acting FSH IVF protocol: a randomized controlled trial.","finding":"","journal":"Reproductive biomedicine online","studyType":"Clinical Study"},{"pmid":"41373024","year":"2025","title":"Feasibility and efficacy of random-start progestin-primed ovarian stimulation: a multicenter pilot randomized controlled trial in oocyte donation.","finding":"","journal":"Reproductive biology and endocrinology : RB&E","studyType":"Clinical Study"},{"pmid":"40680552","year":"2025","title":"A single dose of corifollitropin alfa is equipotent to a daily dose of 300 IU recombinant FSH regardless of ovarian reserve.","finding":"","journal":"Reproductive biomedicine online","studyType":"Clinical Study"},{"pmid":"40674571","year":"2025","title":"Etonogestrel implant for LH suppression in a novel DuoStim ovarian stimulation protocol using overlapping doses of corifollitropin alfa for social egg freezing: a case report.","finding":"","journal":"JBRA assisted reproduction","studyType":"Clinical Study"},{"pmid":"40369953","year":"2025","title":"The efficacy of intraovarian versus subcutaneous corifollitropin alfa administration in DuoStim protocol for infertile women with low in vitro fertilization response.","finding":"","journal":"The journal of obstetrics and gynaecology research","studyType":"Clinical Study"}],"tags":[{"label":"Biologic","category":"modality"},{"label":"Follicle-stimulating hormone receptor","category":"target"},{"label":"FSHR","category":"gene"},{"label":"G03GA09","category":"atc"},{"label":"Active","category":"status"},{"label":"Adolescent males with hypogonadotropic hypogonadism","category":"indication"},{"label":"Ovulation induction","category":"indication"},{"label":"Merck Sharp & Dohme Limited","category":"company"}],"phase":"marketed","safety":{"safetySignals":[{"llr":98.333,"date":"","count":11,"signal":"Ovarian hyperstimulation syndrome","source":"DrugCentral FAERS","actionTaken":"Reported 11 times (LLR=98)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"company":"Merck Sharp & Dohme Limited","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CORIFOLLITROPIN ALFA","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:28:04.044336+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T03:28:21.559270+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:28:12.056796+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-20T03:28:04.116437+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CORIFOLLITROPIN ALFA","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:28:12.361309+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Follicle stimulating hormone receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:28:13.477731+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108185/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:28:13.125020+00:00"}},"allNames":"org 36286","offLabel":[],"synonyms":["corifollitropin alfa","elonva","Org 36286","FSH-CTP"],"timeline":[{"date":"2010-01-25","type":"positive","source":"DrugCentral","milestone":"EMA approval (Merck Sharp & Dohme Limited)"}],"aiSummary":"Corifollitropin Alfa, marketed by Merck Sharp & Dohme Limited, is a follicle-stimulating hormone analog indicated for adolescent males with hypogonadotropic hypogonadism, positioning it in a niche but critical therapeutic area. The drug's mechanism of action, which closely mimics natural FSH, provides a significant advantage in stimulating follicle growth and ovulation effectively. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics and biosimilars.","approvals":[{"date":"2010-01-25","orphan":false,"company":"Merck Sharp & Dohme Limited","regulator":"EMA"}],"brandName":"Org 36286","ecosystem":[{"indication":"Adolescent males with hypogonadotropic hypogonadism","otherDrugs":[],"globalPrevalence":null},{"indication":"Ovulation induction","otherDrugs":[{"name":"clomifene","slug":"clomifene","company":"Sanofi Aventis Us"},{"name":"follitropin","slug":"follitropin","company":"Serono"},{"name":"ganirelix","slug":"ganirelix","company":"Organon Usa Inc"}],"globalPrevalence":null}],"mechanism":{"target":"Follicle-stimulating hormone receptor","targets":[{"gene":"FSHR","source":"DrugCentral","target":"Follicle-stimulating hormone receptor","protein":"Follicle-stimulating hormone receptor"}],"modality":"Biologic","explanation":"","oneSentence":"","technicalDetail":"Corifollitropin Alfa is a recombinant DNA-derived human follicle-stimulating hormone (FSH) analog that selectively binds to the FSH receptor, activating the downstream signaling pathways that regulate follicular growth and ovulation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5245","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CORIFOLLITROPIN%20ALFA","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CORIFOLLITROPIN ALFA","fields":["publications"],"source":"PubMed/NCBI"}],"_emaChecked":true,"_enrichedAt":"2026-03-30T10:17:58.085927","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T03:28:21.559392+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"chorionic gonadotrophin","drugSlug":"chorionic-gonadotrophin","fdaApproval":"","relationship":"same-class"},{"drugName":"follitropin","drugSlug":"follitropin","fdaApproval":"1986-09-18","relationship":"same-class"},{"drugName":"lutropin alfa","drugSlug":"lutropin-alfa","fdaApproval":"2004-10-08","relationship":"same-class"},{"drugName":"choriogonadotropin alfa","drugSlug":"choriogonadotropin-alfa","fdaApproval":"2000-09-20","relationship":"same-class"}],"genericName":"corifollitropin alfa","indications":{"approved":[{"name":"Adolescent males with hypogonadotropic hypogonadism","source":"DrugCentral","snomedId":33927004,"regulator":"FDA"},{"name":"Ovulation induction","source":"DrugCentral","snomedId":61285001,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"chorionic-gonadotrophin","brandName":"chorionic gonadotrophin","genericName":"chorionic gonadotrophin","approvalYear":"","relationship":"same-class"},{"drugId":"follitropin","brandName":"follitropin","genericName":"follitropin","approvalYear":"1986","relationship":"same-class"},{"drugId":"lutropin-alfa","brandName":"lutropin alfa","genericName":"lutropin alfa","approvalYear":"2004","relationship":"same-class"},{"drugId":"choriogonadotropin-alfa","brandName":"choriogonadotropin alfa","genericName":"choriogonadotropin alfa","approvalYear":"2000","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06134479","phase":"PHASE3","title":"Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":["Fertility"],"enrollment":194,"completionDate":"2025-09-09"},{"nctId":"NCT06175832","phase":"PHASE4","title":"PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2025-01-27","conditions":["Ovarian Stimulation","Quality of Life","Preimplantation Genetic Testing","Fertility Preservation"],"enrollment":60,"completionDate":"2027-12-31"},{"nctId":"NCT06193135","phase":"NA","title":"Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2025-07-08","conditions":["Infertility, Female","Reproductive Sterility"],"enrollment":318,"completionDate":"2025-12-31"},{"nctId":"NCT05815719","phase":"PHASE4","title":"Continuous Double Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2022-11-17","conditions":["Fertility Issues"],"enrollment":30,"completionDate":"2023-05-30"},{"nctId":"NCT06635538","phase":"NA","title":"One-shot Ovarian Stimulation Protocol (One-shot)","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2024-10-31","conditions":["Infertility, Female"],"enrollment":20,"completionDate":"2025-04"},{"nctId":"NCT00703014","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07-13","conditions":["Pregnancy","Neonates"],"enrollment":541,"completionDate":"2009-03-15"},{"nctId":"NCT00702338","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05-15","conditions":["Pregnancy","Neonates"],"enrollment":1,"completionDate":"2008-12-15"},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":["Pregnancy","Neonates"],"enrollment":15,"completionDate":"2008-01-15"},{"nctId":"NCT00702273","phase":"","title":"Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-19","conditions":["In Vitro Fertilization"],"enrollment":344,"completionDate":"2009-05-31"},{"nctId":"NCT00702234","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02-15","conditions":["Pregnancy","Neonates"],"enrollment":268,"completionDate":"2010-01-15"},{"nctId":"NCT00598208","phase":"PHASE2","title":"A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05-19","conditions":["Fertilization"],"enrollment":325,"completionDate":"2004-03-15"},{"nctId":"NCT00702585","phase":"PHASE2","title":"Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-08-01","conditions":["Infertility"],"enrollment":55,"completionDate":"2002-10-15"},{"nctId":"NCT00702806","phase":"PHASE2","title":"Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-07-01","conditions":["Infertility","In Vitro Fertilization"],"enrollment":99,"completionDate":"2002-10-15"},{"nctId":"NCT00702195","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-01-01","conditions":["Pregnancy"],"enrollment":29,"completionDate":"2003-09-15"},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":["In Vitro Fertilization"],"enrollment":1509,"completionDate":"2008-01-15"},{"nctId":"NCT01146418","phase":"PHASE3","title":"Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06-02","conditions":["Infertility"],"enrollment":307,"completionDate":"2014-04-29"},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":["Infertility"],"enrollment":397,"completionDate":"2007-11-15"},{"nctId":"NCT00696878","phase":"PHASE3","title":"Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09-26","conditions":["In Vitro Fertilization"],"enrollment":682,"completionDate":"2009-05-15"},{"nctId":"NCT00697255","phase":"PHASE2","title":"A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-15","conditions":["Ovulation Induction"],"enrollment":8,"completionDate":"2008-05-15"},{"nctId":"NCT01709331","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-02-11","conditions":["Hypogonadism","Hypogonadotropic Hypogonadism"],"enrollment":18,"completionDate":"2015-04-08"},{"nctId":"NCT03019575","phase":"PHASE3","title":"Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2017-02-02","conditions":["Hypogonadotropic Hypogonadism"],"enrollment":17,"completionDate":"2020-05-05"},{"nctId":"NCT04695483","phase":"PHASE4","title":"Reduction of Progesterone Elevation at Trigger in POR After Long Acting COS Compared With Daily COS: a Prospective Randomized Trial","status":"COMPLETED","sponsor":"IRCCS San Raffaele","startDate":"2022-02-22","conditions":["Infertility"],"enrollment":110,"completionDate":"2024-05-06"},{"nctId":"NCT04487925","phase":"PHASE4","title":"Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2022-01-25","conditions":["Ovarian Reserve","Poor Responders","IVF"],"enrollment":208,"completionDate":"2024-12-31"},{"nctId":"NCT04586686","phase":"NA","title":"Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":["Breast Cancer Female"],"enrollment":41,"completionDate":"2024-12-31"},{"nctId":"NCT04446845","phase":"PHASE4","title":"Double Stimulation Followed by a Fresh Embryo Transfer","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2020-10-30","conditions":["Infertility"],"enrollment":120,"completionDate":"2023-05-02"},{"nctId":"NCT03197077","phase":"PHASE3","title":"Optimisation of Follicular Recruitment in IVM Cycles","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2017-11-01","conditions":["Infertility, Female","Polycystic Ovary Syndrome"],"enrollment":145,"completionDate":"2022-12-31"},{"nctId":"NCT04482751","phase":"","title":"The Relationship Between Serum AMH Dynamics and Early or Normal Ovarian Response to Corifollitropin Alfa","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2020-08-01","conditions":["Infertility, Female"],"enrollment":80,"completionDate":"2023-09-30"},{"nctId":"NCT02884245","phase":"PHASE3","title":"Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2016-11-04","conditions":["Infertility"],"enrollment":334,"completionDate":"2023-01-04"},{"nctId":"NCT02402192","phase":"PHASE4","title":"Type of Gonadotropin and Embryo Kinetics of Development","status":"TERMINATED","sponsor":"IVI Madrid","startDate":"2015-04","conditions":["Infertility"],"enrollment":201,"completionDate":"2016-12"},{"nctId":"NCT03939390","phase":"PHASE4","title":"Follicular Phase Stimulation vs. Luteal Phase Stimulation in Patients Diagnosed With Suboptimal Response","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2020-01-17","conditions":["Improving Ovarian Stimulation; Suboptimal Responders"],"enrollment":41,"completionDate":"2022-04-02"},{"nctId":"NCT03555942","phase":"NA","title":"Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2018-05-08","conditions":["Infertility"],"enrollment":44,"completionDate":"2021-12-01"},{"nctId":"NCT01408615","phase":"","title":"A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-09-20","conditions":["Infertility, Female"],"enrollment":472,"completionDate":"2016-11-18"},{"nctId":"NCT01599494","phase":"PHASE3","title":"An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2014-03","conditions":["Infertility"],"enrollment":0,"completionDate":"2015-06"},{"nctId":"NCT00702988","phase":"","title":"Pregnancy & Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 (Study 38827)(P06056)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-10-01","conditions":["Pregnancy","Neonates"],"enrollment":44,"completionDate":"2005-02-28"},{"nctId":"NCT00702624","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-04","conditions":["Pregnancy","Neonates"],"enrollment":113,"completionDate":"2008-06"},{"nctId":"NCT00702546","phase":"","title":"Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12","conditions":["In Vitro Fertilization"],"enrollment":102,"completionDate":"2008-12"},{"nctId":"NCT01144416","phase":"PHASE3","title":"Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06","conditions":["Infertility"],"enrollment":1424,"completionDate":"2012-04"},{"nctId":"NCT00647933","phase":"PHASE1","title":"An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-06","conditions":["Infertility"],"enrollment":24,"completionDate":"2000-12"},{"nctId":"NCT00702351","phase":"PHASE2","title":"A Trial of Single Dose Corifollitropin Alfa's Ability to Induce Multiple Follicular Growth During the First Week of Controlled Ovarian Stimulation for IVF or ICSI (38833)(P05788)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-12-09","conditions":["In Vitro Fertilization"],"enrollment":50,"completionDate":"2007-07-11"},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":["Reproductive Issues","Reproductive Disorder","Fertility Disorders","Fertility Issues","Gynecologic Disease","IVF"],"enrollment":5484,"completionDate":"2021-01-20"},{"nctId":"NCT03939403","phase":"PHASE4","title":"Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2019-11-18","conditions":["Ovarian Stimulation"],"enrollment":180,"completionDate":"2021-05-08"},{"nctId":"NCT01319695","phase":"PHASE1,PHASE2","title":"Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2011-01","conditions":["Infertility"],"enrollment":140,"completionDate":"2017-08"},{"nctId":"NCT03208972","phase":"PHASE4","title":"Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG","status":"COMPLETED","sponsor":"AZ Jan Palfijn Gent","startDate":"2014-10","conditions":["Infertility"],"enrollment":107,"completionDate":"2015-11"},{"nctId":"NCT03877185","phase":"","title":"A New Revolutionary 3-Injection- Protocol in Infertile Women","status":"UNKNOWN","sponsor":"Assisting Nature","startDate":"2018-07-01","conditions":["Infertility, Female"],"enrollment":100,"completionDate":"2021-12"},{"nctId":"NCT04416607","phase":"NA","title":"Corifollitropin Alpha and Ovarian Response","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2018-06-15","conditions":["Infertility, Female"],"enrollment":300,"completionDate":"2019-01-31"},{"nctId":"NCT04142190","phase":"","title":"Corifollitropin Alfa and Embryo Morphokinetics","status":"COMPLETED","sponsor":"Kinderwunsch Institut GmbH","startDate":"2013-01","conditions":["Infertility"],"enrollment":1351,"completionDate":"2018-12"},{"nctId":"NCT03177538","phase":"PHASE4","title":"Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2017-09-04","conditions":["Infertility, Female"],"enrollment":32,"completionDate":"2019-09-10"},{"nctId":"NCT03686852","phase":"NA","title":"Effect of Recombinant Follicular Stimulating Hormone (FSH) Dosing Following Cori-follitropin Alfa","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2019-05-01","conditions":["Infertility"],"enrollment":261,"completionDate":"2020-05-01"},{"nctId":"NCT03816670","phase":"NA","title":"Prospective Randomized Trial Comparing Corifollitropin-alfa Late Start vs. Corifollitropin-alfa Standard Start in Expected Poor, Normal and High-responders Undergoing IVF","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2017-04-01","conditions":["Fertility Disorders"],"enrollment":113,"completionDate":"2018-12-31"},{"nctId":"NCT02606500","phase":"PHASE4","title":"Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2016-03","conditions":["Obesity"],"enrollment":70,"completionDate":"2017-03"},{"nctId":"NCT02757287","phase":"PHASE4","title":"Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors","status":"WITHDRAWN","sponsor":"Fundacion Dexeus","startDate":"2016-05","conditions":["Infertility"],"enrollment":0,"completionDate":"2018-12-01"},{"nctId":"NCT03480412","phase":"","title":"Second Step Protocol in Poor Ovarian Responder (POR)","status":"UNKNOWN","sponsor":"Università degli Studi 'G. d'Annunzio' Chieti e Pescara","startDate":"2017-09-01","conditions":["Infertility, Female","Premature Ovarian Failure","Fertility Disorders"],"enrollment":50,"completionDate":"2019-09"},{"nctId":"NCT03354494","phase":"","title":"Desogestrel (DSG) and Corifolitropin (FSH-CTP) Alfa for Ovarian Stimulation in Donors","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2016-01","conditions":["Controlled Ovaria Stimulation"],"enrollment":40,"completionDate":"2017-09"},{"nctId":"NCT02466204","phase":"PHASE4","title":"Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients","status":"COMPLETED","sponsor":"Vietnam National University","startDate":"2015-06-01","conditions":["Infertility"],"enrollment":400,"completionDate":"2017-08-15"},{"nctId":"NCT02118051","phase":"PHASE3","title":"Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2013-09","conditions":["Infertility"],"enrollment":234,"completionDate":"2017-06"},{"nctId":"NCT02490150","phase":"PHASE4","title":"Corifollitropin Alfa on D5 Versus D7 After Contraceptive Pill","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2015-02","conditions":["Oocyte Donation"],"enrollment":70,"completionDate":"2016-06"},{"nctId":"NCT01816321","phase":"PHASE3","title":"Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2013-03","conditions":["Infertility","Poor Ovarian Response"],"enrollment":150,"completionDate":"2016-05"},{"nctId":"NCT02448459","phase":"PHASE1","title":"COmbining Oral Letrozole and Clomiphene for Ovarian Stimulation (COOL-COS) Associated With Corifollitropin Alfa: a Pilot Study","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2015-05","conditions":["Infertility"],"enrollment":40,"completionDate":"2016-05"},{"nctId":"NCT02254928","phase":"PHASE4","title":"Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders","status":"TERMINATED","sponsor":"Vida Recoletas Sevilla","startDate":"2014-09","conditions":["Infertility"],"enrollment":26,"completionDate":"2015-11"},{"nctId":"NCT01206803","phase":"","title":"Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2010-09","conditions":["Infertility, Subfertility"],"enrollment":294,"completionDate":"2014-01"},{"nctId":"NCT02213627","phase":"PHASE4","title":"Use of Corifolitropin Alfa in Oocyte Donors","status":"UNKNOWN","sponsor":"IVI Madrid","startDate":"2014-10","conditions":["Female Reproductive Problem","Infertility"],"enrollment":300,"completionDate":"2015-12"},{"nctId":"NCT02471677","phase":"PHASE4","title":"Corifollitropin Alfa Versus Follitropin Beta in High Responders","status":"UNKNOWN","sponsor":"Eugonia","startDate":"2015-09","conditions":["Infertility"],"enrollment":62,"completionDate":"2016-12"},{"nctId":"NCT01633580","phase":"PHASE4","title":"D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2011-12","conditions":["Infertility"],"enrollment":67,"completionDate":"2013-03"},{"nctId":"NCT02215135","phase":"PHASE4","title":"Corifollitropin Alfa Application in PCOS Patients","status":"UNKNOWN","sponsor":"Shin Kong Wu Ho-Su Memorial Hospital","startDate":"2014-01","conditions":["In Vitro Fertilization"],"enrollment":30,"completionDate":""},{"nctId":"NCT02046655","phase":"PHASE4","title":"Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2011-01","conditions":["Subfertility"],"enrollment":80,"completionDate":""},{"nctId":"NCT02070198","phase":"PHASE4","title":"Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF","status":"UNKNOWN","sponsor":"Bioroma","startDate":"2013-12","conditions":["Female Infertility","Poor Responder"],"enrollment":120,"completionDate":"2014-12"},{"nctId":"NCT01732094","phase":"PHASE2","title":"Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2012-07","conditions":["Infertility","Poor Ovarian Response"],"enrollment":57,"completionDate":"2013-05"},{"nctId":"NCT01732068","phase":"PHASE2","title":"Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2012-07","conditions":["Infertility","Poor Ovarian Response"],"enrollment":51,"completionDate":"2013-05"}],"_emaApprovals":[{"date":"2010-01-25","status":"Authorised","company":"Merck Sharp & Dohme Limited"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"013500","UNII":"T7K20Y2GWY","INN_ID":"7738","UMLSCUI":"C2713522","chemblId":"CHEMBL2108185","ChEMBL_ID":"CHEMBL2108185","KEGG_DRUG":"D08895","DRUGBANK_ID":"DB09066","SNOMEDCT_US":"703830001","MESH_SUPPLEMENTAL_RECORD_UI":"C437186"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Merck Sharp & Dohme Limited","relationship":"Original Developer"}],"publicationCount":130,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"G03GA09","allCodes":["G03GA09"]},"biosimilarFilings":[],"originalDeveloper":"Merck Sharp & Dohme Limited","recentPublications":[{"date":"2026 Mar","pmid":"41637911","title":"Risk of progesterone elevation in patients with low ovarian reserve using long-acting FSH IVF protocol: a randomized controlled trial.","journal":"Reproductive biomedicine online"},{"date":"2025 Dec 10","pmid":"41373024","title":"Feasibility and efficacy of random-start progestin-primed ovarian stimulation: a multicenter pilot randomized controlled trial in oocyte donation.","journal":"Reproductive biology and endocrinology : RB&E"},{"date":"2025 Sep","pmid":"40680552","title":"A single dose of corifollitropin alfa is equipotent to a daily dose of 300 IU recombinant FSH regardless of ovarian reserve.","journal":"Reproductive biomedicine online"},{"date":"2025 Sep 22","pmid":"40674571","title":"Etonogestrel implant for LH suppression in a novel DuoStim ovarian stimulation protocol using overlapping doses of corifollitropin alfa for social egg freezing: a case report.","journal":"JBRA assisted reproduction"},{"date":"2025 May","pmid":"40369953","title":"The efficacy of intraovarian versus subcutaneous corifollitropin alfa administration in DuoStim protocol for infertile women with low in vitro fertilization response.","journal":"The journal of obstetrics and gynaecology research"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Merck Sharp & Dohme Limited","companyId":"merck","modality":"Recombinant protein","firstApprovalDate":"2010","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":3,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T03:28:21.559392+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}